Countries Australia
Imagion Reports Positive Results in Phase I Study for MagSense® HER2 Imaging Agent
Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety...
December 14, 2023 | News
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate
Clover Biopharmaceuticals, Ltd. a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...
December 13, 2023 | News
First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging
The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...
December 12, 2023 | News
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its progression to the second st...
December 12, 2023 | News
IonOpticks and Newomics Collaborate to Boost Aurora Series Columns Compatibility with Agilent Mass Spectrometers
IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, ef...
December 07, 2023 | News
ObvioHealth and Chemist Warehouse Partner to Power Clinical Trial Efficiency in Australia
The partnership gives sponsors easier access to a wider pool of participants by driving awareness about trials to Chemist Warehouse's customers in Australi...
December 06, 2023 | News
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled a...
November 30, 2023 | News
Merz Therapeutics Receives TGA Approval for XEOMIN® in Australia
This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...
November 23, 2023 | News
Prospection AI Launches Single-source Patient-centric Platform in Australia to Boost Drug Commercialization
-Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-cent...
November 21, 2023 | News
Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam
CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...
November 14, 2023 | News
George Clinical and Medidata Partner in Australia to Boost Operational Efficiency in Clinical Trials
Medidata, a Dassault Systèmes company, announced that George Clinical, a leading global clinical research organization, is leveraging Medidata's clo...
November 14, 2023 | News
P&G's Gillette and Braun Join Forces with Movember to Tackle Men's Health Crisis in Australia
In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is...
November 13, 2023 | News
AdvanCell Doses First Patient in 212Pb-ADVC001 Clinical Trial for Metastatic Prostate Cancer in Australia
“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...
November 09, 2023 | News
The Resilience and Growth of Australia's Pharmaceutical Manufacturing Industry: A Glimpse into the Future
Historical Context Australia has a long history of pharmaceutical manufacturing dating back to the early 20th century. The industry primarily focused on t...
November 08, 2023 | Analysis
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
